LOCATION: | ALDH9A1peptideisasyntheticpeptidecorrespondingtotheinternalregionofALDH9A1. |
---|---|
SPECIES: | Human |
TESTEDAPPLICATIONS: | Blocking |
APPLICATIONS: | ALDH9A1PeptideisusedforblockingtheactivityofALDH9A1antibody(catalognumber42-615).TheALDH9A1antibodyshipsat0.5mg/mLandtheALDH9A1Peptideshipsasa100μgpellet.Whenpeptideisreconstitutedin200μLwater,theconcentrationwillbe0.5mg/mL,identicaltothatoftheantibody.Thebeststartingratiowouldbe1:1(whichmeansmolarexcessofpeptiderelativetoantibodywhenidenticalvolumesaremixed).Mixequalvolumeofpeptideandantibodyattherequireddilutionandleaveatambienttemperaturefor20minutes.Thenincubateanddevelopinparalleltwoblots:onewiththeantibodyandonewiththeantibodywhichhasbeenpre-absorbedwiththeprovidedpeptide. |
PHYSICALSTATE: | Lyophilized |
---|---|
BUFFER: | ALDH9A1peptideissuppliedas100μgofdriedpeptide.Whenthepeptideisreconstitutedin200μLwater,theconcentrationwillbe0.5mg/mL. |
STORAGECONDITIONS: | Storeat-20˚C.Whenreconstitutedminimizefreezingandthawing. |
ALTERNATENAMES: | E3,ALDH4,ALDH7,ALDH9,TMABADH,4-trimethylaminobutyraldehydedehydrogenase,AldehydedehydrogenaseE3isozyme |
---|---|
ACCESSIONNO.: | NP_000687.3 |
PROTEINGINO.: | 115387104 |
ProSci Inc.始终开放以支持研究需求,同时确保我们员工的健康和安全。ProSci拥有广泛的冠状病毒SARS-CoV-2 重组蛋白和抗体产品组合, 并将继续积极开发新的冠状病毒 产品。此外,ProSci的定制抗体服务也保持开放状态,以支持研究团体开发 研究工具,诊断,疗法和疫苗。